Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 5
2005 1
2006 1
2007 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.
Mannila MN, Silveira A, Hawe E, Eriksson P, Aillaud MF, Juhan-Vague I, Yudkin J, Margaglione M, di Minno G, Mussoni L, Tremoli E, Humphries S, Hamsten A; HIFMECH Study Group. Mannila MN, et al. Thromb Haemost. 2004 Dec;92(6):1240-9. doi: 10.1160/TH04-06-0339. Thromb Haemost. 2004. PMID: 15583729
Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study.
Kelberman D, Hawe E, Luong LA, Mohamed-Ali V, Lundman P, Tornvall P, Aillaud MF, Juhan-Vague I, Yudkin JS, Margaglione M, di Minno G, Tremoli E, Humphries SE; HIFMECH study group. Kelberman D, et al. Thromb Haemost. 2004 Nov;92(5):1122-8. doi: 10.1160/TH04-04-0202. Thromb Haemost. 2004. PMID: 15543342
Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study.
Morange PE, Saut N, Alessi MC, Frere C, Hawe E, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Humphries SE, Juhan-Vague I; HIFMECH Study Group. Morange PE, et al. Atherosclerosis. 2005 Apr;179(2):317-23. doi: 10.1016/j.atherosclerosis.2004.10.014. Epub 2004 Dec 24. Atherosclerosis. 2005. PMID: 15777548
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.
Juhan-Vague I, Morange PE, Frere C, Aillaud MF, Alessi MC, Hawe E, Boquist S, Tornvall P, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Humphries SE; HIFMECH Study Group. Juhan-Vague I, et al. J Thromb Haemost. 2003 Nov;1(11):2322-9. doi: 10.1046/j.1538-7836.2003.00458.x. J Thromb Haemost. 2003. PMID: 14629464 Free article.
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
Juhan-Vague I, Morange PE, Aubert H, Henry M, Aillaud MF, Alessi MC, Samnegård A, Hawe E, Yudkin J, Margaglione M, Di Minno G, Hamsten A, Humphries SE; HIFMECH Study Group. Juhan-Vague I, et al. Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):867-73. doi: 10.1161/01.atv.0000015445.22243.f4. Arterioscler Thromb Vasc Biol. 2002. PMID: 12006404
11 results